Inhibrx Inc logo

Inhibrx Inc

NAS:INBX (USA)  
$ 24.16 +1.13 (+4.91%) 10:08 PM EST
P/E:
At Loss
P/B:
69.63
Market Cap:
$ 1.05B
Enterprise V:
$ 1.03B
Volume:
421.54K
Avg Vol (2M):
384.92K
Volume:
421.54K
Market Cap $:
1.05B
PE Ratio:
At Loss
Avg Vol (2M):
384.92K
Enterprise Value $:
1.03B
PB Ratio:
69.63

Business Description

Description
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
Name Current Vs Industry Vs History
Cash-To-Debt 1.13
Equity-to-Asset 0.06
Debt-to-Equity 13.74
Debt-to-EBITDA -1.46
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.54
Distress
Grey
Safe
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 52.29
9-Day RSI 51.49
14-Day RSI 53.43
6-1 Month Momentum % -34.22
12-1 Month Momentum % 55.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.47
Quick Ratio 7.47
Cash Ratio 7.18
Days Sales Outstanding 80.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.8

Financials (Next Earnings Date:2023-08-08 Est.)

INBX's 30-Y Financials
Balance Sheet Breakdown
Cashflow Statement Breakdown

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:INBX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Inhibrx Inc Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.28
EPS (TTM) ($) -3.94
Beta 0
Volatility % 105.22
14-Day RSI 53.43
14-Day ATR ($) 1.711315
20-Day SMA ($) 24.9785
12-1 Month Momentum % 55.01
52-Week Range ($) 7.67 - 34.72
Shares Outstanding (Mil) 43.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Inhibrx Inc Filings

Document Form Filing Date
No Filing Data

Inhibrx Inc Stock Events

Event Date Price($)
No Event Data

Inhibrx Inc Frequently Asked Questions

What is Inhibrx Inc(INBX)'s stock price today?
The current price of INBX is $24.16. The 52 week high of INBX is $34.72 and 52 week low is $7.67.
When is next earnings date of Inhibrx Inc(INBX)?
The next earnings date of Inhibrx Inc(INBX) is 2023-08-08 Est..
Does Inhibrx Inc(INBX) pay dividends? If so, how much?
Inhibrx Inc(INBX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1